Sullivan Eddie Joe
Insider CIK 1889712 · SABS PRESIDENT, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2026-02-03 | 2026-02-05 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-08-26 | 2025-08-28 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 4,447 | — | $0 | 4,447 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 46,528 | — | $0 | 46,528 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-02-21 | 2024-02-23 | 190,000 | — | $0 | 190,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | P Buy | 2023-12-07 | 2023-12-08 | 1,740 | $0.88 | $1.5K | 5,232,304 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2023-03-14 | 2023-03-16 | 525,000 | — | $0 | 525,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | P Buy | 2022-09-07 | 2022-09-08 | 14,000 | $0.74 | $10.4K | 5,230,564 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2022-03-16 | 2022-03-18 | 21,218 | — | $0 | 21,218 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-10-22 | 2021-10-26 | 2,106,361 | — | $0 | 2,106,361 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-10-22 | 2021-10-26 | 197,374 | — | $0 | 197,374 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-10-22 | 2021-10-26 | 139,585 | — | $0 | 139,585 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-10-22 | 2021-10-26 | 162,850 | — | $0 | 162,850 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-10-22 | 2021-10-26 | 162,850 | — | $0 | 162,850 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2021-10-22 | 2021-10-26 | 23,264 | — | $0 | 23,264 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award | 2021-10-22 | 2021-10-26 | 5,213,764 | — | $0 | 5,213,764 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award | 2021-10-07 | 2021-10-26 | 2,800 | $10.07 | $28.2K | 2,800 | SEC↗ |